Asset Details
Do you wish to reserve the book?
BMP10 suppresses hepatocellular carcinoma progression via PTPRS–STAT3 axis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
BMP10 suppresses hepatocellular carcinoma progression via PTPRS–STAT3 axis
Do you wish to request the book?
BMP10 suppresses hepatocellular carcinoma progression via PTPRS–STAT3 axis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
BMP10 suppresses hepatocellular carcinoma progression via PTPRS–STAT3 axis
2019
Overview
Bone morphogenetic protein 10 (BMP10), one member of the BMP family, is involved in various development events. Dysregulation of BMP10 has been observed in several diseases, including hypertensive cardiac hypertrophy, Hirschsprung disease and blood vessel formation. However, its role in liver cancer remains largely unknown. In this study, we reported that BMP10 was significantly downregulated in HCC at both mRNA and protein level. Decreased BMP10 was associated with bigger tumor size, worse TNM stage, earlier recurrence and poorer survival. BMP10 negatively regulated HCC cell proliferation in vitro and in vivo. Mechanism study revealed that BMP10 suppressed tumor cell growth by inhibiting STAT3 signaling. Interestingly, we found that cytoplasmic BMP10 interacted with both receptor protein tyrosine phosphatase sigma (PTPRS) and STAT3, which facilitated dephosphorylation of STAT3 by PTPRS. Altogether, our study has revealed the clinical significance of BMP10 in HCC, and suppression of HCC cell growth by BMP10 via PTPRS–STAT3 axis, providing a potential therapeutic strategy for targeting STAT3 signaling in HCC.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 38/109
/ 38/89
/ 96
/ Adult
/ Animals
/ Biomarkers, Tumor - genetics
/ Biomarkers, Tumor - metabolism
/ Bone Morphogenetic Proteins - genetics
/ Bone Morphogenetic Proteins - metabolism
/ Cancer
/ Carcinoma, Hepatocellular - genetics
/ Carcinoma, Hepatocellular - metabolism
/ Carcinoma, Hepatocellular - pathology
/ Female
/ Gene Expression Regulation, Neoplastic
/ Heart
/ Humans
/ Liver Neoplasms - metabolism
/ Male
/ Medicine
/ Mice
/ mRNA
/ Oncology
/ Protein-tyrosine-phosphatase
/ Proteins
/ Receptor-Like Protein Tyrosine Phosphatases, Class 2 - genetics
/ Receptor-Like Protein Tyrosine Phosphatases, Class 2 - metabolism
/ RNA
/ STAT3 Transcription Factor - genetics
